FDA Updates

FDA advisory panel says OTC cough and cold meds should not be used by children under six.

Wyeth recalls certain Robitussin, Dimetapp Cold & Chest Congestion.

FDA meeting on ingredients in OTC oral nasal decongestants.

NextWave Pharmaceuticals and Kerr Drug to provide MyKidz Iron

FDA to hold joint meeting to evaluate Merck's OTC use of Mevacor to help lower cholesterol and prevent heart attack.

FDA's behind-the-counter drugs proposal draws mixed reactions from pharmacy associations

Branded pharmaceuticals, generics, OTCs, home-health products, health and beauty items

Eaton Apothecary to distribute InforMedix Holdings' Med-eMonitor.

Makers of homeopathic products push their cough and cold remedies in the wake of the withdrawal OTC cough and cold products for infants.

Several manufacturers withdraw over-the-counter cough and cold products

New branded Rxs, OTCs, home health care items, health & beauty, etc.

This article reveals new vitamins and dietary supplements that promote eye health.

FDA seeks comments on behind-the-counter drugs

FDA advisory committee to discuss OTC cough/ cold products in children under six

Wyeth's new Advil Maximum Strength waiting for FDA approval.

Genetic differences predict anti-inflammatory benefits from nutritional products

NACDS Foundation Chain Pharmacy Industry Profile highlights role of pharmacists

TWC Global issues recall of Axcil and Desirin

Treatments suggested include probiotics coupled with fructooligosaccharides. zinc pyrithione products, glycemic support products, and homeopathic medicines.

Review of new branded drugs, generics, OTCs, home health products, health and beauty aids, etc.

FDA's proposal for new sunscreen regulations address UVA rays as well as other measures consumers may take to protect themselves from UVB rays.

New lung cancer guidelines are released from the American College of Chest Physicians.

Bodee's Zencore Tabs recalled

FDA warns Melanocorp over illegal sale of Melanotan II

New drug approvals for branded drugs, generics, plus OTCs, home health care, health and beauty, etc.

The Consumer Healthcare Products Association is providing educational programs to stop DXM abuse in teens. It also discusses what manufacturers are voluntarily doing to stop teens from purchasing large quantities of cough and cold medicines which contain the ingredients dextromethorphan.

Biopure Corp. has drafted a protocol for patients with life-threatening anemia for whom blood transfusion is not feasible to obtain its investigational product Hemopure (HBOC-201) on a compassionate-use basis.

The FDA has issued an advisory warning for parents never to give cough and cold medicines to children under the age of two unless instructed to do so by a doctor.